Mativ Holdings Inc Dossier - Source-backed chat

Mativ Holdings Inc

MATVNYSE

SectorMaterials

IndustrySpecialty Chemicals

Beta (adjusted)0.92

Intrinsic Value $15.89median of 3 methodsbased on filings through 30 Jun 2026

Market Price $11.65Price as of 1 Oct 2026

UndervaluedIntrinsic value is 36% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $643M

Enterprise Value $1.6B

Shares Outstanding 55M diluted

Moat Rating None

Next Earnings Date5 Nov 2026

Last ex-dividend28 Aug 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Mativ Holdings, Inc. (MATV) represents a classic value-recovery and operational turnaround play following the complex 2022 merger of SWM and Neenah. The company has successfully pruned its portfolio by divesting its low-growth Engineered Papers business to focus on high-value specialty materials across its Filtration & Advanced Materials (FAM) and Sustainable & Adhesive Solutions (SAS) segments. While operational execution is showing positive momentum—evidenced by expanding gross margins and robust underlying free cash flow—the investment thesis remains constrained by elevated financial leverage (net leverage at 4.1x) and high interest expenses. A 'Hold' recommendation is warranted until further deleveraging is achieved and organic volume growth stabilizes.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets1 analysts · as of 18 Aug 2026

Low · most bearish analyst$21.00

Mean target$21.00

High · most bullish analyst$21.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$5.7315%

The bear case is triggered by a prolonged macroeconomic downturn or persistent raw material inflation that compresses margins. If high interest rates persist and organic volumes decline further, free cash flow generation will be severely pressured. Under this scenario, the company struggles to reduce its $953.5 million net debt load, raising refinancing risks for its staggered maturities starting in 2029 and leading to a downward valuation adjustment.

Base CaseCentral scenario

$10.4260%

The base case assumes a gradual, steady operational recovery. Revenue remains relatively flat to slightly positive as soft macro demand is offset by targeted pricing actions. Gross margins continue to expand due to cost-saving initiatives (targeting $40 million in overhead savings by the end of 2026). Free cash flow remains positive and comfortably covers the $0.40 annual dividend, while excess cash is systematically directed toward debt reduction, gradually lowering leverage.

Bull CaseUpside scenario

$21.4225%

The bull case is driven by rapid deleveraging, accelerated realization of the remaining merger synergies, and a cyclical rebound in industrial demand. If customer destocking fully concludes and high-margin filtration and protective solutions experience strong organic growth, Mativ's operating leverage will drive substantial EBITDA expansion. Under this scenario, net leverage quickly drops below 3.0x, triggering a significant valuation rerating toward specialty materials peers.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong market positions in attractive global product categories supported by secular megatrends in clean air/water, healthcare, and sustainable packaging.
Demonstrated execution on cost synergies, with significant progress toward the $40 million overhead savings target by the end of 2026.
Attractive dividend yield of approximately 5% supported by positive underlying free cash flow generation.
Successful portfolio pruning, including the exit from the low-growth tobacco paper business, allowing 100% focus on high-margin advanced materials.

Key Investment Risks

Elevated financial leverage with net debt of approximately $953.5 million and a net leverage ratio of 4.1x.
High interest expense burdening net income and limiting the cash available for growth-oriented capital expenditures.
Exposure to cyclical industrial end-markets and volatile raw material input costs.
Execution and integration risks associated with ongoing global asset realignment initiatives.

Thesis Invalidation Triggers

Net leverage ratio rising above 4.5x.
Quarterly adjusted EBITDA margin falling below 8.5%.
Free cash flow turning negative on a trailing twelve-month basis, threatening the sustainability of the dividend payout.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.